道琼斯指数
52,395.58
涨跌
+34.0+0.06%
在 MEXC 探索美国生物科技板块股票,涵盖专注于药物研发、基因治疗及生物学研究的公司。比较股价、当日涨跌、市值和成交量,全面了解生物科技行业动态。

今日美股市场走势分化,道琼斯指数涨跌幅为 +0.06%,标普 500 指数为 +0.57%,纳斯达克综合指数为 +1.12%。个股方面,2,445 只上涨、2,672 只下跌,市场整体呈现分化格局。
| # | 股票 | 52 周价格区间 | |||||
|---|---|---|---|---|---|---|---|
| 1 | Amgen Inc.AMGN | $447.41 | +0.34% | 957.43K | $241.88B | $288.00 - $450.98 | 0.02% |
| 2 | Gilead Sciences Inc.GILD | $158.69 | -0.13% | 3.08M | $196.76B | $114.02 - $160.51 | 0.02% |
| 3 | Moderna, Inc.MRNA | $207.68 | +4.25% | 15.85M | $82.91B | $22.28 - $254.48 | 0.00% |
| 4 | IQVIA Holdings Inc.IQV | $272.03 | -0.26% | 1.63M | $44.78B | $154.50 - $289.73 | 0.00% |
| 5 | Revolution Medicines, Inc.RVMD | $186.67 | +1.55% | 809.96K | $40.01B | $55.40 - $224.31 | 0.00% |
| 6 | Biogen Inc.BIIB | $253.28 | 0.00% | 671.86K | $37.42B | $138.00 - $254.41 | 0.00% |
| 7 | Incyte Genomics Inc.INCY | $116.30 | +2.25% | 1.21M | $23.57B | $84.02 - $132.60 | 0.00% |
| 8 | Medpace Holdings, Inc.MEDP | $675.36 | -0.39% | 138.79K | $18.89B | $373.00 - $684.52 | 0.00% |
| 9 | Charles River Laboratories International, Inc.CRL | $357.30 | -0.16% | 690.21K | $17.06B | $146.19 - $360.40 | 0.00% |
| 10 | Exelixis Inc.EXEL | $65.34 | +0.22% | 918.02K | $16.19B | $36.00 - $65.58 | 0.00% |
| 11 | Neurocrine Biosciences Inc.NBIX | $146.00 | -0.15% | 725.00K | $14.84B | $122.14 - $186.12 | 0.00% |
| 12 | Halozyme Therapeutics, Inc.HALO | $128.52 | +0.08% | 895.56K | $14.59B | $61.23 - $128.91 | 0.00% |
| 13 | Bio-Techne Corp.TECH | $72.64 | -0.08% | 1.98M | $11.39B | $43.20 - $72.75 | 0.00% |
| 14 | Twist Bioscience CorporationTWST | $159.99 | +9.48% | 1.41M | $10.03B | $23.30 - $219.71 | 0.00% |
| 15 | Repligen Corp.RGEN | $174.86 | -3.12% | 1.48M | $9.87B | $100.99 - $198.87 | 0.00% |
| 16 | Kymera Therapeutics, Inc.KYMR | $118.42 | +3.14% | 519.85K | $9.85B | $55.66 - $130.05 | 0.00% |
| 17 | Krystal Biotech, Inc.KRYS | $318.05 | +1.86% | 124.07K | $9.41B | $183.26 - $382.54 | 0.00% |
| 18 | ImmunityBio, Inc.IBRX | $8.64 | +10.76% | 8.38M | $9.16B | $1.95 - $12.43 | 0.00% |
| 19 | Vaxcyte, Inc.PCVX | $61.11 | +1.23% | 1.68M | $9.09B | $39.87 - $90.75 | 0.00% |
| 20 | Iovance Biotherapeutics, Inc.IOVA | $14.57 | +5.88% | 7.05M | $6.60B | $1.76 - $15.37 | 0.00% |
| 21 | Immunovant, Inc.IMVT | $28.88 | +2.01% | 636.32K | $5.97B | $19.21 - $45.42 | 0.00% |
| 22 | Kodiak Sciences Inc.KOD | $90.47 | +1.42% | 667.51K | $5.69B | $15.83 - $104.00 | 0.00% |
| 23 | CG Oncology, Inc.CGON | $63.47 | +3.22% | 240.68K | $5.63B | $35.80 - $80.97 | 0.00% |
| 24 | Scholar Rock Holding CorporationSRRK | $42.51 | +2.10% | 430.24K | $5.18B | $27.07 - $61.76 | 0.00% |
| 25 | CRISPR Therapeutics AGCRSP | $51.32 | +4.35% | 724.46K | $4.96B | $44.12 - $67.73 | 0.00% |
| 26 | Adaptive Biotechnologies CorporationADPT | $27.61 | +5.75% | 947.46K | $4.41B | $12.00 - $30.74 | 0.00% |
| 27 | Relay Therapeutics, Inc.RLAY | $18.85 | +3.64% | 1.57M | $4.13B | $5.95 - $21.27 | 0.00% |
| 28 | Tarsus Pharmaceuticals, Inc.TARS | $71.03 | +1.31% | 207.09K | $3.50B | $53.89 - $91.53 | 0.00% |
| 29 | Denali Therapeutics Inc.DNLI | $19.21 | +2.41% | 962.40K | $3.07B | $13.75 - $27.30 | 0.00% |
| 30 | Beam Therapeutics Inc.BEAM | $24.75 | +4.20% | 1.98M | $2.56B | $20.23 - $38.26 | 0.00% |
| 31 | ADMA Biologics, Inc.ADMA | $11.15 | +0.27% | 1.28M | $2.50B | $7.21 - $20.46 | 0.00% |
| 32 | Vericel CorporationVCEL | $43.26 | +1.39% | 351.35K | $2.22B | $28.95 - $49.32 | 0.00% |
| 33 | Recursion Pharmaceuticals, Inc.RXRX | $4.05 | +6.32% | 18.22M | $2.17B | $2.77 - $6.50 | 0.00% |
| 34 | BioCryst Pharmaceuticals Inc.BCRX | $8.05 | +2.41% | 6.43M | $2.06B | $6.23 - $11.22 | 0.00% |
| 35 | Vir Biotechnology, Inc.VIR | $11.58 | +4.80% | 1.29M | $1.96B | $4.82 - $12.00 | 0.00% |
| 36 | Absci CorporationABSI | $10.61 | +12.49% | 4.88M | $1.82B | $2.24 - $12.05 | 0.00% |
| 37 | Maze Therapeutics, Inc.MAZE | $31.70 | +0.93% | 300.36K | $1.72B | $21.95 - $53.65 | 0.00% |
| 38 | Novavax Inc.NVAX | $10.05 | +6.12% | 5.32M | $1.66B | $6.20 - $13.38 | 0.00% |
| 39 | Hemab Therapeutics Holdings, Inc.COAG | $38.32 | +6.50% | 235.02K | $1.61B | $23.00 - $55.42 | 0.00% |
| 40 | Inhibrx Biosciences, Inc.INBX | $97.18 | +9.78% | 294.63K | $1.43B | $53.39 - $155.29 | 0.00% |
| 41 | Taysha Gene Therapies, Inc.TSHA | $4.25 | +5.61% | 1.83M | $1.39B | $3.46 - $7.30 | 0.00% |
| 42 | Replimune Group, Inc.REPL | $13.06 | +4.57% | 3.19M | $1.23B | $1.50 - $16.33 | 0.00% |
| 43 | Vor Biopharma Inc.VOR | $19.32 | +4.58% | 486.31K | $1.14B | $6.50 - $28.66 | 0.00% |
| 44 | Cullinan Therapeutics, Inc.CGEM | $14.88 | +1.75% | 259.00K | $957.60M | $6.73 - $23.19 | 0.00% |
| 45 | Odyssey Therapeutics, Inc.ODTX | $19.61 | +0.31% | 181.15K | $941.95M | $15.10 - $29.05 | 0.00% |
| 46 | Monte Rosa Therapeutics, Inc.GLUE | $10.65 | +1.34% | 919.05K | $908.59M | $9.68 - $25.77 | 0.00% |
| 47 | MeiraGTx Holdings plcMGTX | $9.41 | +2.29% | 456.51K | $904.24M | $6.62 - $15.35 | 0.00% |
| 48 | Prime Medicine, Inc.PRME | $4.36 | +20.50% | 7.77M | $789.90M | $2.67 - $5.20 | 0.00% |
| 49 | Sana Biotechnology, Inc.SANA | $2.46 | +3.60% | 1.70M | $734.93M | $2.22 - $5.70 | 0.00% |
| 50 | OmniAb, Inc.OABI | $4.92 | +6.83% | 725.84K | $713.99M | $1.30 - $5.43 | 0.00% |
| 现货美股(RealStocks) | 代币化美股(Tokenized Stocks) | 股票合约(Stock Futures) | |
|---|---|---|---|
| 是什么 | 美股上市公司的真实股份(现货美股) | 与美股/ETF 挂钩的区块链代币 | 以 USDT 保证金进行的股价合约交易 |
| 所有权 | 是 —— 真实持股 | 否 —— 仅为合成敞口 | 否 —— 仅为衍生品敞口 |
| 股东权益 | 有(如分红) | 无 | 无 |
| 交易时间 | 美股交易时段(盘前、正常、盘后、隔夜) | 24/7 全天候 | 支持交易对最高可达 24/7 全天候 |
| 持仓方式 | 买入并持有 | 买入并持有 | 支持多空双向、杠杆交易 |
| 适合人群 | 追求长期持有和分红收益的投资者 | 希望全天候获得股票敞口、无需持有股票的交易者 | 希望通过杠杆进行投机或对冲的短线/活跃交易者 |
通过 MEXC 合作的持牌券商购买真实美股,并可按适用条件享有股息等股东权益。
覆盖 7,000+ 只美国上市股票及 ETF,涵盖科技、金融、医疗、消费等多个行业。
支持 USDT 转入及 USDT/USD 转换,更便捷地为 RealStocks 账户提供资金。
以具有竞争力的交易成本参与真实美股交易,让更多资金用于投资策略。
本页面展示的美股价格、指数、排行榜、图表及其他市场数据可能来自第三方数据提供商,并可能存在延迟或误差。MEXC 提供的相关信息仅供参考和教育用途,不对其准确性或完整性作出保证。页面内容不构成任何金融或投资建议,也不构成买卖任何证券的推荐。美股交易存在风险,历史表现不代表未来结果,用户应在作出投资决定前进行独立研究。